{"id":"doi:10.1038/s41423-020-00565-9","kind":"review","title":"Tumor-infiltrating lymphocytes in the immunotherapy era","authors":["Sterre T. Paijens","Annegé Vledder","Marco de Bruyn","Hans W. Nijman"],"author_count":4,"year":2020,"published":"2020-11-02","venue":"Cellular and Molecular Immunology","cited_by":886,"doi":"10.1038/s41423-020-00565-9","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41423-020-00565-9","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41423-020-00565-9","updated":null,"pmid":"33139907","pmcid":null,"openalex_id":"W3096715224","pdf_url":"https://www.nature.com/articles/s41423-020-00565-9.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}